ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
심방 중격 결손 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에 CAGR은 7.3%를 나타낼 것으로 예측되고 59억 1,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 수술 전후 관리를 위한 원격 의료 활용 증가, 유전적·표현형 데이터 기반 맞춤형 치료 계획 확대, 특히 신흥 시장을 중심으로 한 전 세계 의료비 지출 지속적 증가, 노령 인구 증가로 인한 후천적 선천성 심장병 진단 사례 증가, 의료기기 규제의 국제적 조화로 인한 전 세계 시장 진출 확대, 선천성 심장병 조기 발견 및 치료를 목표로 한 국가 및 국제 보건 프로그램 시행 등에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 새로운 최소 침습적 ASD 폐쇄 장치 개발, 진단 개선 및 맞춤형 치료 계획 수립을 위한 인공지능(AI) 및 머신 러닝 활용, 장치 제조를 위한 생분해성 및 생체흡수성 소재 도입, ASD 시술 중 실시간 모니터링 및 의사 결정 뒷받침을 위한 AI 기반 도구, 환자 회복 추적 및 합병증 조기 감지를 위한 원격 모니터링 기술 채택 등이 포함됩니다.
향후 5년간 7.3% 성장률 전망은 해당 시장에 대한 이전 추정치 대비 0.5% 소폭 하향 조정된 수치입니다. 이 같은 하향 조정은 주로 미국과 타국 간 관세 부과 영향에 기인합니다. 관세 부과로 인해 스웨덴과 독일에서 수입되는 폐쇄 장치 및 경식도 심초음파 장비의 비용이 증가하여 미국 소아 심장학 분야에 차질이 발생할 수 있으며, 이로 인해 선천성 심장 결손 보수가 지연되고 수술 비용이 상승할 가능성이 있습니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 영향이 더욱 광범위하게 될 것입니다.
선천성 심장 결손(CHD) 유병률 증가로 심방 중격 결손 시장은 성장할 것으로 예상됩니다. 이러한 결손은 출생 시부터 존재하는 심장의 구조적 이상입니다. 심방중격결손 치료는 심실 간 비정상적 혈류를 교정하고 심장 기능을 개선하며 관련 합병증을 감축하여 CHD 관리에 핵심적입니다. 예를 들어, 2024년 6월 호주 보건복지연구소가 발표한 데이터에 따르면 호주에서는 소아와 성인을 포함하여 약 65,000명이 선천성 심장병을 갖고 생활하고 있다는 것이 밝혀졌습니다. 선천성 심장병과 관련된 입원은 2020-21년에 약 5,900건을 차지하고, 1세 미만의 유아 사망은 79건으로, 유아 사망 전체의 7.8%를 차지하고 있습니다. 이 데이터는 심방 중격 결손 시장 성장의 촉진력을 부각시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 심방 중격 결손 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 심방 중격 결손 시장 : 성장률 분석
세계의 심방 중격 결손 시장 실적 : 규모와 성장(2019-2024년)
세계의 심방 중격 결손 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 심방 중격 결손 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 심방 중격 결손 시장 : 치료 시술별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
수술적 폐쇄
경 카테터 폐쇄
하이브리드 시술
약물치료
세계의 심방 중격 결손 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
흉부 X선 검사
심전도
심장 카테터 검사
경식도 심초음파 검사
맥박 산소 측정
세계의 심방 중격 결손 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
의료기기
의약품
세계의 심방 중격 결손 시장 : 연령층별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
소아
성인용
세계의 심방 중격 결손 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 심방 중격 결손 시장, 경 카테터 폐쇄 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
기기 기반 폐쇄(Amplatzer 중격 폐쇄기)
경 카테터 플러그 폐쇄 기술
성인 및 소아 환자를 위한 카테터 기반 ASD 복구
세계의 심방 중격 결손 시장, 하이브리드 수술 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
수술적 및 경 카테터 기술 조합
최소침습 하이브리드 수술
복잡하거나 대규모 ASD를 위한 하이브리드 폐쇄술
세계의 심방 중격 결손 시장, 약물 치료 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
항응고 치료(뇌졸중 예방)
이뇨제(증상 관리용)
강압제(관련 질환 관리용)
다른 의약품 적응 외 사용
제7장 지역별 및 국가별 분석
세계의 심방 중격 결손 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 심방 중격 결손 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
심방 중격 결손 시장 : 경쟁 구도
심방 중격 결손 시장 : 기업 프로파일
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Medtronic plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Siemens Healthineers : 개요, 제품 및 서비스, 전략 및 재무 분석
Boston Scientific Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Philips Healthcare : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Edwards Lifesciences Corporation
WL Gore & Associates Inc.
St. Jude Medical LLC
Cook Medical
Lepu Medical Technology Co. Ltd.
MicroPort Scientific Corporation
Lifetech Scientific Corporation
Venus Medtech Hangzhou Inc
Occlutech Holding AG
Coherex Medical
Osypka AG
Arjo AB
Heart Medical Europe BV
AtriCure Inc.
Asklepion Pharmaceuticals LLC
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
심방 중격 결손 시장(2029년) : 새로운 기회를 제공하는 국가
심방 중격 결손 시장(2029년) : 새로운 기회를 제공하는 부문
심방 중격 결손 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
An atrial septal defect (ASD) is a congenital heart defect characterized by an abnormal opening in the septum, the wall separating the heart's two upper chambers (atria). This opening allows oxygen-rich blood from the left atrium to mix with oxygen-poor blood in the right atrium, leading to increased blood flow to the lungs and potential complications such as pulmonary hypertension and heart failure over time.
The main treatment options for atrial septal defects include surgical closure, transcatheter closure, hybrid procedures, and medication therapy. Surgical closure involves repairing or sealing the abnormal opening through surgical intervention. Diagnostic techniques used for ASD include chest x-rays, electrocardiograms, cardiac catheterization, transesophageal echocardiography, and pulse oximetry. These diagnostics are facilitated by medical devices and pharmaceutical products and are utilized in pediatric and adult patients across various healthcare settings, including hospitals, ambulatory surgical centers, cardiac clinics, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The arterial septal defect research report is one of a series of new reports from The Business Research Company that provides arterial septal defect market statistics, including the arterial septal defect industry's global market size, regional shares, competitors with an arterial septal defect market share, detailed arterial septal defect market segments, market trends and opportunities, and any further data you may need to thrive in the arterial septal defect industry. This arterial septal defect market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The atrial septal defect market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.46 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise in number of congenital heart disease cases, increased funding for research and development of ASD treatments, high awareness about congenital heart defects among parents and healthcare providers, higher rates of pediatric surgeries, approval of new ASD closure devices and therapies by regulatory bodies like the FDA, expansion of healthcare facilities.
The atrial septal defect market size is expected to see strong growth in the next few years. It will grow to $5.91 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increased use of telemedicine for pre and post-operative care, growth in personalized treatment plans based on genetic and phenotypic data, continued increase in global healthcare spending, particularly in emerging markets, growing elderly population leading to a higher incidence of congenital heart defects being diagnosed later in life international harmonization of medical device regulations improving global market penetration, implementation of national and international health programs targeting early detection and treatment of congenital heart diseases. Major trends in the forecast period include development of new, minimally invasive ASD closure devices, the use of AI and machine learning for improved diagnosis and personalized treatment planning, introduction of biodegradable and bioresorbable materials for device manufacturing, AI-driven tools for real-time monitoring and decision support during ASD procedures, adoption of remote monitoring technologies to track patient recovery and detect complications early.
The forecast of 7.3% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. pediatric cardiology by increasing costs for occluder devices and transesophageal echocardiography equipment imported from Sweden and Germany, potentially prolonging congenital heart defect repairs and raising surgical costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The atrial septal defect market is anticipated to grow due to the rising prevalence of congenital heart defects (CHD). These defects are structural abnormalities in the heart that exist from birth. Treating atrial septal defects is crucial for managing CHD by correcting abnormal blood flow between the heart's chambers, improving heart function, and reducing associated complications. For example, data from the Australian Institute of Health and Welfare in June 2024 revealed that around 65,000 individuals in Australia, including children and adults, live with congenital heart disease. Hospitalizations related to congenital heart disease accounted for about 5,900 cases in the 2020-21 period, with 79 deaths occurring in infants under one year old, representing 7.8% of all infant deaths. This data underscores the driving force behind the atrial septal defect market's growth.
Key players in the arterial septal defect market are focusing on developing advanced devices and obtaining approvals to expand their availability and applications. Device approval is essential for gaining official authorization or certification from regulatory bodies before manufacturing, selling, or using a device in specific markets or purposes. For instance, in March 2024, Occlutech GmbH announced the FDA's approval of their Occlutech ASD Occluder and Occlutech Pistol Pusher for treating atrial septal defects (ASD). This milestone approval allows Occlutech to commercialize their devices in the US through an exclusive partnership with B. Braun Interventional Systems. The Occlutech ASD Occluder, a self-expanding nitinol device, offers a lifelong solution for patients with confirmed defects, enhancing healthcare globally.
In February 2022, Boston Scientific Corporation acquired Baylis Medical Company Inc. for $1.75 billion. This acquisition expands Boston Scientific's product portfolios in electrophysiology and structural heart interventions with Baylis Medical's transseptal platforms, guidewires, and left heart access tools, including the VersaCross RF Wire designed for creating atrial septal defects.
Major companies operating in the atrial septal defect market are Abbott Laboratories, Medtronic plc, Siemens Healthineers, Boston Scientific Corporation, Philips Healthcare, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., St. Jude Medical LLC, Cook Medical, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Lifetech Scientific Corporation, Venus Medtech Hangzhou Inc, Occlutech Holding AG, Coherex Medical, Osypka AG, Arjo AB, Heart Medical Europe BV, AtriCure Inc., Asklepion Pharmaceuticals LLC
North America was the largest region in the atrial septal defect market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial septal defect market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the atrial septal defect market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The atrial septal defect (ASD) market consists of revenues earned by entities by provide services such as diagnosis and monitoring, medication management, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial septal defect (ASD) market also includes sales of septal occluder devices, cardiac MRI systems, and anticoagulant medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Atrial Septal Defect Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on atrial septal defect market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for atrial septal defect ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The atrial septal defect market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3) By Product Type: Medical Devices; Pharmaceutical Products
4) By Age Group: Pediatric; Adult
5) By End-User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Other End-Users
Subsegments:
1) By Surgical Closure: Open Heart Surgery (Traditional Surgical Closure); Minimally Invasive Surgical Closure; Patches (Pericardial, Synthetic) For Asd Closure
2) By Transcatheter Closure: Device-Based Closure (Amplatzer Septal Occluder); Transcatheter Plug Closure Techniques; Catheter-Based Asd Repair For Adult And Pediatric Patients
3) By Hybrid Procedures: Combination Of Surgical And Transcatheter Techniques; Minimally Invasive Hybrid Procedures; Hybrid Closure For Complex Or Large Asds
4) By Medication Therapy: Anticoagulant Therapy (To Prevent Stroke); Diuretics (For Managing Symptoms); Antihypertensive Drugs (For Managing Associated Conditions); Off-Label Use Of Other Medications
Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers; Boston Scientific Corporation; Philips Healthcare; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; St. Jude Medical LLC; Cook Medical; Lepu Medical Technology Co. Ltd.; MicroPort Scientific Corporation; Lifetech Scientific Corporation; Venus Medtech Hangzhou Inc; Occlutech Holding AG; Coherex Medical; Osypka AG; Arjo AB; Heart Medical Europe BV; AtriCure Inc.; Asklepion Pharmaceuticals LLC
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Atrial Septal Defect Market Characteristics
3. Atrial Septal Defect Market Trends And Strategies
4. Atrial Septal Defect Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Atrial Septal Defect Growth Analysis And Strategic Analysis Framework
5.1. Global Atrial Septal Defect PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Atrial Septal Defect Market Growth Rate Analysis
5.4. Global Atrial Septal Defect Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Atrial Septal Defect Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Atrial Septal Defect Total Addressable Market (TAM)
6. Atrial Septal Defect Market Segmentation
6.1. Global Atrial Septal Defect Market, Segmentation By Treatment Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgical Closure
Transcatheter Closure
Hybrid Procedures
Medication Therapy
6.2. Global Atrial Septal Defect Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chest X-Ray
Electrocardiogram
Cardiac Catheterization
Transesophageal Echocardiography
Pulse Oximetry
6.3. Global Atrial Septal Defect Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical Devices
Pharmaceutical Products
6.4. Global Atrial Septal Defect Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric
Adult
6.5. Global Atrial Septal Defect Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Cardiac Clinics
Other End-Users
6.6. Global Atrial Septal Defect Market, Sub-Segmentation Of Surgical Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Open Heart Surgery (Traditional Surgical Closure)
Minimally Invasive Surgical Closure
Patches (Pericardial, Synthetic) For Asd Closure
6.7. Global Atrial Septal Defect Market, Sub-Segmentation Of Transcatheter Closure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Device-Based Closure (Amplatzer Septal Occluder)
Transcatheter Plug Closure Techniques
Catheter-Based Asd Repair For Adult And Pediatric Patients
6.8. Global Atrial Septal Defect Market, Sub-Segmentation Of Hybrid Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Combination Of Surgical And Transcatheter Techniques
Minimally Invasive Hybrid Procedures
Hybrid Closure For Complex Or Large Asds
6.9. Global Atrial Septal Defect Market, Sub-Segmentation Of Medication Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
